Patent 12496077
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Active provider: Google · gemini-2.5-flash
Proceedings on file (0)
All PTAB activity →AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.
Current assignee: Angiodynamics Inc
No PTAB proceedings on file. This patent has not been challenged via IPR, PGR, or CBM. The absence is itself a signal — well-asserted patents eventually attract IPRs. The LLM analysis below may surface filings the ODP feed hasn’t indexed yet.
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Proceedings overview
There are no AIA trial proceedings currently on file for U.S. Patent 12,496,077, according to the USPTO Open Data Portal API and recent web searches. This means the patent's validity has not yet been challenged before the Patent Trial and Appeal Board (PTAB). For a defendant, this indicates that all claims remain untested in this forum, and the patent owner's defensive posture is currently unassailed by PTAB actions.
Strategic summary
As of May 30, 2026, U.S. Patent 12,496,077 has no recorded PTAB proceedings. This implies that all claims (Independent Claims 1, 2, 3, and Method Claims 1, 2, as outlined in the patent summary) remain legally presumed valid as they have not been challenged or adjudicated by the PTAB.
Since no PTAB trials have been initiated, there is no estoppel landscape to consider under 35 U.S.C. § 315(e)(2). A potential defendant facing assertion of this patent would not be barred from raising any prior-art grounds in a future PTAB petition (e.g., IPR or PGR) or in district court litigation, subject to the statutory timeframes and requirements for such filings.
The absence of PTAB activity is a notable signal for a recently granted patent (issued December 16, 2025). While Post-Grant Review (PGR) petitions can be filed within nine months of the patent grant, the window for an Inter Partes Review (IPR) typically opens nine months after the patent grant or reissue, or after the termination of a PGR. Given the patent's recent issue date, it is still relatively early for an IPR to have been filed. However, the nine-month window for a PGR is still active (until around September 16, 2026). The lack of any proceedings could indicate that the patent has not yet been widely asserted, or that potential challengers are still evaluating their options.
Recommended next steps
Since no PTAB activity currently exists for U.S. Patent 12,496,077, the recommended next steps are as follows:
- Monitor for new filings: Continuously monitor the PTAB's Patent Trial and Appeal Case Tracking System (P-TACTS) for any newly filed petitions against US12496077.
- Evaluate PGR potential: If you are a potential defendant, consider the possibility of filing a Post-Grant Review (PGR) petition, as the 9-month window from the patent's issue date (December 16, 2025) is still open. PGR allows challenges on any ground of invalidity (except best mode).
- Assess IPR potential: Begin preparing an analysis for a potential Inter Partes Review (IPR) challenge, which would become available after September 16, 2026. IPRs are limited to challenges based on prior art patents or printed publications under 35 U.S.C. §§ 102 and 103.
- Prior art search: Conduct a thorough prior art search to identify strong grounds for challenging the patentability of the claims, should an assertion arise.
Generated 5/30/2026, 6:47:16 PM